成人外源性脂质性肺炎的临床影像特征、病因及临床病程
诊断多经肺活检确认(71%),仅41%患者CT可见脂肪衰减。中位随访1.2年,20%慢性呼吸道症状患者改善而50%恶化;CT异常中位随访1年,33%改善或消退而39%进展。
要点
- ELP常无症状,CT脂肪衰减仅见于41%患者,诊断困难。
- 多数患者临床和影像异常持续或恶化,即使停用致病物。
- 病情恶化者年龄更大,胃肠道疾病患病率更高。
核心结论
- ELP常无症状且CT可无脂肪衰减表现。
- 多数患者临床和影像异常持续或恶化,即使停用致病物。
研究设计与样本
- 纳入标准:组织病理学脂质性肺炎、BAL液脂质负载巨噬细胞或胸部CT脂肪衰减,且临床诊断LP并排除内源性LP。
主要发现
- 平均年龄71岁,无性别优势,一半无症状。
- 诊断方式:肺活检71%(包括3例因疑似恶性肿瘤行肺叶切除),CT 24%,BAL 5%。
- 多数患者双肺实质阴影,常累及下叶,仅41%可识别脂肪衰减。
- 79%患者确定致病物质,多数在诊断后确定。
- 中位随访1.2年,慢性呼吸道症状患者仅20%改善,50%恶化;中位随访1年,CT异常33%改善或消退,39%进展。
临床怎么用
- ELP诊断需结合病史、影像及病理,CT脂肪衰减阴性不能排除。
- 停用致病物后仍需长期随访,警惕临床和影像进展。
- 对高龄合并胃肠道疾病患者应加强监测。
局限性
- 致病物质多在诊断后确定,可能存在回忆偏倚。
- 随访时间有限,中位1.2年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exogenous lipoid pneumonia (ELP) develops when lipid-containing substances enter the airways through aspiration or inhalation and incite an inflammatory response. The diagnosis of ELP often is difficult because findings may be nonspecific. The clinical course of ELP has not been well characterized. RESEARCH QUESTION: What are the presenting clinicoradiologic features of ELP, its causative agents, and clinical course? STUDY DESIGN AND METHODS: We searched the Mayo Clinic electronic medical records for patients diagnosed with ELP between 1998 and 2020. Inclusion diagnostic criteria were: (1) lipoid pneumonia (LP) on histopathologic examination, (2) lipid-laden macrophages in BAL fluid, or (3) fatty attenuation of parenchymal opacities on chest CT imaging. Additionally, all patients were required to have a clinician diagnosis of LP in the absence of conditions known to cause endogenous LP. RESULTS: Thirty-four patients were identified. Mean age was 71 years, with no sex predominance; one-half were asymptomatic. The diagnosis was confirmed by lung biopsy (including three lobectomies for suspected malignancy) in 71% of patients, CT scan in 24% of patients, and BAL in 5% of patients. Most patients manifested bilateral parenchymal opacities that commonly involved the lower lobes; fatty attenuation was identifiable in only 41% of patients. A causative substance was identified in 79% of patients, in most cases after the diagnosis was established. Over a median follow-up of 1.2 years, only 20% of patients with chronic respiratory symptoms improved, whereas 50% worsened. Over a median follow-up interval of 1 year, CT scan abnormalities improved or resolved in 33% of patients and progressed in 39% of patients. Patients who deteriorated were older, with a higher prevalence of GI disorders than those who remained stable or improved. INTERPRETATION: ELP often is asymptomatic and may not manifest fatty attenuation on chest CT imaging. Clinical and radiologic abnormalities persist or worsen in most affected patients, even when the causative agent is discontinued.
引用
- Samhouri BF, Tandon YK, Hartman TE, et al. Presenting Clinicoradiologic Features, Causes, and Clinical Course of Exogenous Lipoid Pneumonia in Adults. Chest. 2021. PMID: 33647249. doi:10.1016/j.chest.2021.02.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。